Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
US Army
Express Scripts
Citi
Cantor Fitzgerald
Teva
Chubb
Boehringer Ingelheim
Medtronic

Generated: May 20, 2018

DrugPatentWatch Database Preview

PENETREX Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Penetrex patents expire, and what generic alternatives are available?

Penetrex is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in PENETREX is enoxacin. There are three drug master file entries for this compound. Additional details are available on the enoxacin profile page.
Summary for PENETREX
Drug patent expirations by year for PENETREX
Medical Subject Heading (MeSH) Categories for PENETREX
Synonyms for PENETREX
011E588
1-ethyl-6-fluoranyl-4-oxidanylidene-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid
1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7- [1-piperazinyl]-1,8-naphthyridine-3-carboxylic acid
1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid
1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-1,8-naphthyridine-3-carboxylic acid
1-Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid
1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid
1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid
1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid
1-ethyl-6-fluoro-4-oxo-7-piperazinylhydropyridino[2,3-b]pyridine-3-carboxylic acid
1, 6-fluoro-1,4-dihydro- 4-oxo-7-piperazinyl
1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-
1,8-Naphthyridine-3-carboxylic acid, 6-fluoro-1,4-dihydro-4-oxo-7-piperazinyl
325OGW249P
74011-58-8
8-naphthyridine-3-carboxylic acid
84294-96-2
84294-96-2 (.1.5H2O)
A837996
AB00052328_10
AB00052328_11
AB00052328-09
AB0014125
AB1011529
AC1L1FGQ
AK163523
AKOS015838626
Almitil
Almitil (TN)
AN-37251
AT 2266
AT-2266
AT2266
Bactidan
Bactidan (TN)
Bactidron
Bactidron (TN)
BCBcMAP01_000009
BDBM50296358
BIDD:GT0191
BPBio1_000491
BRD-K78113049-001-05-5
BRD-K78113049-001-12-1
BRN 3628995
BSPBio_000445
BSPBio_003080
C06979
C15H17FN4O3
CAS-74011-58-8
CCG-39452
CCRIS 5242
CHEBI:157175
CHEMBL826
CI 919
CI-919
CI919
CL23362
Comprecin
Comprecin (TN)
CS-2257
CTK8E3243
D00310
D0R8ER
DB00467
DivK1c_000420
DR001414
DSSTox_CID_2984
DSSTox_GSID_22984
DSSTox_RID_76818
DTXSID5022984
E0762
enofloxacin
Enofloxacine
Enoksetin
Enoksetin (TN)
Enoram
enoxacin
Enoxacin (Penetrex)
Enoxacin (USAN/INN)
Enoxacin [USAN:BAN:INN:JAN]
Enoxacin [USAN:INN:BAN:JAN]
Enoxacin Sesquihydrate
Enoxacin, analytical standard
Enoxacina
Enoxacine
Enoxacine [French]
Enoxacino
Enoxacino [Spanish]
Enoxacinum
Enoxacinum [Latin]
Enoxen
Enoxen (TN)
Enoxin
Enoxin (TN)
Enoxor
Enoxor (TN)
Enroxil (TN)
Epitope ID:119069
Faulding Brand of Enoxacin
Flumark
Flumark (TN)
FT-0630825
GTPL8882
Gyramid (TN)
HE384816
HMS1569G07
HMS1922I17
HMS2090E10
HMS2092N20
HMS2233K20
HMS3372A12
HMS3655M08
HMS501E22
HY-B0268
I06-0290
IDI1_000420
IDYZIJYBMGIQMJ-UHFFFAOYSA-N
J10280
K259
KB-87029
KBio1_000420
KBio2_002019
KBio2_004587
KBio2_007155
KBio3_002580
KBioGR_000651
KBioSS_002019
KS-5190
LS-95946
MCULE-2632820619
MFCD00133308
MLS000069645
MLS006011976
MolPort-003-666-456
NCGC00016927-01
NCGC00016927-02
NCGC00016927-03
NCGC00016927-04
NCGC00016927-05
NCGC00016927-06
NCGC00016927-07
NCGC00016927-08
NCGC00016927-10
NCGC00016927-11
NCGC00023864-03
NCGC00023864-04
NCGC00178309-01
NCGC00178309-02
NCI60_009618
NE58656
NINDS_000420
NSC 627409
NSC 629661
NSC-629661
NSC-758416
NSC629661
NSC758416
Oprea1_147866
PD 107779
PD-107779
PD107779
Penetrex (TN)
Pharmakon1600-01503215
Pierre Fabre Brand of Enoxacin Sesquihydrate
Prestwick_708
Prestwick0_000353
Prestwick1_000353
Prestwick2_000353
Prestwick3_000353
Rhone Poulenc Rorer Brand of Enoxacin Sesquihydrate
Rhone-Poulenc Rorer Brand of Enoxacin Sesquihydrate
s1756
SBI-0051788.P002
SC-13757
SCHEMBL33963
Sesquihydrate, Enoxacin
SMP1_000113
SMR000058233
SPBio_001802
SPBio_002366
Spectrum_001539
SPECTRUM1503215
Spectrum2_001731
Spectrum3_001570
Spectrum4_000166
Spectrum5_001044
SR-01000000202
SR-01000000202-2
ST044514
TL8005116
Tox21_110688
Tox21_110688_1
TR-037960
UNII-325OGW249P
Vinone (TN)
Z1551429746
ZINC19594549

US Patents and Regulatory Information for PENETREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us PENETREX enoxacin TABLET;ORAL 019616-004 Dec 31, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us PENETREX enoxacin TABLET;ORAL 019616-005 Dec 31, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for PENETREX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us PENETREX enoxacin TABLET;ORAL 019616-004 Dec 31, 1991 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us PENETREX enoxacin TABLET;ORAL 019616-004 Dec 31, 1991 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us PENETREX enoxacin TABLET;ORAL 019616-005 Dec 31, 1991 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us PENETREX enoxacin TABLET;ORAL 019616-005 Dec 31, 1991 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
McKesson
Merck
Cerilliant
Teva
Baxter
Colorcon
Mallinckrodt
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.